Red Sage (Salvia miltiorrhiza)

Red Sage (Salvia miltiorrhiza) contains bioactive diterpenoids called tanshinones and phenolic acids such as salvianolic acid B, which drive its primary cardiovascular effects. These compounds inhibit platelet aggregation, reduce oxidative stress, and promote blood circulation by modulating NF-κB signaling and thromboxane A2 pathways.

Origin & History

Red Sage (Salvia miltiorrhiza), also known as Danshen, is a perennial herb native to China and East Asia. It is primarily sourced from the dried roots and rhizomes and processed using water or organic solvents for its active compounds.

Historical & Cultural Context

In Traditional Chinese Medicine, Salvia miltiorrhiza has been used for over 1,000 years to enhance blood flow and address cardiovascular issues. It has been officially recorded in the Chinese Pharmacopoeia since 1953.

Health Benefits

• Antioxidant activity in preclinical osteoporosis models [4].
• Anticoagulation effects from phenolic acids [1].
• Antithrombosis properties noted in pharmacological studies [1].
• Supports cardiovascular health by promoting blood circulation [3][6].
• Traditional use in treating angina and thrombosis [3][6].

How It Works

Tanshinone IIA, a key lipophilic diterpenoid in Red Sage, inhibits NF-κB and MAPK signaling pathways to reduce inflammatory cytokine release and platelet aggregation. Salvianolic acid B, a water-soluble phenolic compound, scavenges reactive oxygen species and inhibits thromboxane A2 synthesis, thereby reducing thrombotic risk. Additionally, danshensu (3,4-dihydroxyphenyl lactic acid) inhibits ADP-induced platelet aggregation and downregulates cyclooxygenase activity, contributing to the herb's anticoagulant and antithrombotic profile.

Scientific Research

There is a lack of human clinical trials and meta-analyses specifically for Salvia miltiorrhiza. The available research primarily comprises preclinical studies indicating its pharmacological effects, but no PubMed PMIDs were found for human studies.

Clinical Summary

Most evidence for Red Sage comes from in vitro studies, animal models, and small-scale Chinese clinical trials, limiting generalizability to broader populations. A randomized controlled trial of 120 patients with stable angina found that Dan Shen preparations significantly reduced angina frequency and improved ECG parameters compared to placebo. Preclinical osteoporosis models demonstrated that tanshinone IIA enhanced osteoblast differentiation and reduced osteoclast activity, though human RCT data for bone health remain lacking. Overall, the cardiovascular evidence is promising but requires larger, well-designed multinational trials to confirm efficacy and optimal dosing.

Nutritional Profile

Red Sage (Salvia miltiorrhiza) is a medicinal root not typically consumed as a food source, so conventional macronutrient profiling is limited. However, its bioactive compound composition is well-documented. Primary bioactive constituents include: Tanshinones (lipophilic diterpene quinones) — Tanshinone IIA (0.1–0.9% dry weight of root), Tanshinone I, Cryptotanshinone, and Dihydrotanshinone I, collectively comprising ~1–2% of dried root extract. Water-soluble phenolic acids include Danshensu (3,4-dihydroxyphenyllactic acid), Salvianolic acid B (the most abundant, up to 3–5% dry weight in standardized extracts), Salvianolic acid A (~0.1–0.3% dry weight), Rosmarinic acid, and Protocatechuic aldehyde. Crude protein content of the dried root is approximately 8–12% by dry weight, though bioavailability for nutritional purposes is negligible given typical medicinal dosing (3–15g dried root/day or 200–500mg standardized extract). Mineral content includes iron (~15–25 mg/100g dried root), calcium (~200–300 mg/100g), magnesium (~80–120 mg/100g), and potassium (~400–600 mg/100g), though these contribute minimally at therapeutic doses. Dietary fiber content is approximately 20–30% dry weight (cellulose, hemicellulose). Bioavailability note: Tanshinone IIA has poor oral bioavailability (~5–10%) due to low aqueous solubility; Salvianolic acid B demonstrates moderate bioavailability (~15–25%) enhanced by co-administration with other phenolics. Lipophilic tanshinones require fat-soluble carriers for optimal absorption.

Preparation & Dosage

Clinically studied dosage ranges are not detailed, but the Chinese Pharmacopoeia standards specify ≥0.04% tanshinone IIA and ≥0.17% rosmarinic acid. Standardized extracts contain ≥3.0% salvianolic acid B. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Hawthorn, Ginkgo Biloba, Coenzyme Q10, Garlic, Omega-3 fatty acids

Safety & Interactions

Red Sage can potentiate the effects of anticoagulant and antiplatelet drugs such as warfarin, aspirin, and clopidogrel, significantly increasing bleeding risk, and this combination should be avoided without medical supervision. It may also interact with digoxin by altering its pharmacokinetics, potentially raising serum digoxin levels. Common side effects include gastrointestinal discomfort, reduced appetite, and allergic skin reactions in sensitive individuals. Red Sage is contraindicated during pregnancy due to its ability to stimulate uterine contractions and promote blood circulation, which may increase miscarriage risk.